Dr. Cunningham is the Associate Director of Research at GreenLight , where he leads teams focused on cell-free technology development and manages the metabolic engineering research efforts of multiple projects aimed at generating commercial products using GreenLight’s cell-free platform. Prior to joining GreenLight, Dr. Cunningham obtained a Doctor of Philosophy degree in Chemical Engineering from Carnegie Mellon University, where his doctoral efforts focused on producing DNA vaccines in bacterial hosts that were engineered using rational, model-predicted mutational strategies and synthetic biology. While attending Carnegie Mellon, Dr. Cunningham was an NIH Biotechnology Training Grant Fellow and received the Ken Meyer Graduate Research Award for research excellence. Dr. Cunningham also holds a Bachelor of Science degree in Chemical Engineering from the University of Pittsburgh, where he was the recipient of a Professional Promise Award by the American Institute of Chemical Engineers. Dr. Cunningham is an author of peer-reviewed publications in the fields of metabolic engineering, bacteriology, and biotechnology. In addition, he is an inventor on several provisional patents pertaining to cell-free bioprocessing and pathway engineering.